nach oben

Erschienen in:

13.08.2019 | Hepatobiliary-Pancreas

Can we differentiate HIV-associated obliterative portopathy from liver cirrhosis using MRI?

verfasst von: Esther Chouraqui, Laura Leguilloux, Anthony Dohan, Hervé Gouya, Matthias Barral, Anais Vallet-Pichard, Philippe Sogni, Stanislas Pol, Vincent Mallet, Philippe Soyer

Erschienen in: European Radiology | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Abstract

Aim

To describe the magnetic resonance imaging (MRI) features of HIV-associated obliterative portopathy (HIV-OP) and determine the most indicative appearance of this condition on MRI by using a retrospective case-control study.

Methods

MRI examinations of 24 patients with HIV-OP (16 men, 8 women; mean age = 48 ± 6.6 [SD] years; age range, 35–71 years) were analyzed by two blinded observers and compared with those obtained in 18 HIV-infected patients with hepatic cirrhosis (14 men, 4 women; mean age = 51 ± 3.4 [SD] years; age range, 35–60 years). Images were qualitatively and quantitatively analyzed with respect to imaging presentation. Comparisons were performed using uni- and multivariate analyses.

Results

Regular liver contours had the highest accuracy for the diagnosis of HIV-OP (83%, 35 of 42; 95% confidence interval [CI], 69–93%) and was the most discriminating independent variable for the diagnosis of HIV-OP (odds ratio, 51; 95%CI, 4.96–1272%) (p < 0.0001). At multivariate analysis, the width of segment 4 in millimeters (OR = 1.23 [95%CI, 1.05–1.44%]; p = 0.011) and the presence of regular liver contours (OR = 7.69 [95%CI, 1.48–39.92%]; p = 0.015) were the variables independently associated with the diagnosis of HIV-OP.

Conclusions

Regular liver contours are the most discriminating independent variable for the diagnosis of HIV-OP but have limited accuracy. Familiarity with this finding may help differentiate HIV-OP from cirrhosis in HIV-infected patients.

Key Points

• Regular liver contour is the most discriminating independent variable for the diagnosis of HIV-OP (odds ratio = 51) with 83% accuracy.

• At multivariate analysis, the width of segment 4 in millimeters and the presence of regular liver contours are the variables independently associated with the diagnosis of HIV-OP.

• MRI helps diagnose HIV-OP in the presence of several categorical findings, which are more frequently observed in HIV-OP patients than in HIV patients with cirrhosis.

Nur mit Berechtigung zugänglich

Khanna R, Sarin SK (2014) Non-cirrhotic portal hypertension - diagnosis and management. J Hepatol 60:421–441PubMed

Rajesh S, Mukund A, Sureka B, Bansal K, Ronot M, Arora A (2018) Non-cirrhotic portal hypertension: an imaging review. Abdom Radiol 43:1991–2010

Krasinskas AM, Eghtesad B, Kamath PS, Demetris AJ, Abraham SC (2005) Liver transplantation for severe intrahepatic noncirrhotic portal hypertension. Liver Transpl 11:627–634PubMed

Isabel Fiel M, Thung SN, Hytiroglou P, Emre S, Schiano TD (2007) Liver failure and need for liver transplantation in patients with advanced hepatoportal sclerosis. Am J Surg Pathol 31:607–614PubMed

Nakanuma Y, Tsuneyama K, Ohbu M, Katayanagi K (2001) Pathology and pathogenesis of idiopathic portal hypertension with an emphasis on the liver. Pathol Res Pract 197:65–76PubMed

Hillaire S, Bonte E, Denninger MH et al (2002) Idiopathic non-cirrhotic intrahepatic portal hypertension in the west: a re-evaluation in 28 patients. Gut 51:275–280PubMedPubMedCentral

Vispo E, Morello J, Rodriguez-Novoa S, Soriano V (2011) Noncirrhotic portal hypertension in HIV infection. Curr Opin Infect Dis 24:12–18PubMed

Krishnan P, Fiel MI, Rosenkrantz AB et al (2012) Hepatoportal sclerosis: CT and MRI appearance with histopathologic correlation. AJR Am J Roentgenol 198:370–376PubMed

Wanless IR (1990) Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules. Hepatology 11:787797

10.

Mallet V, Blanchard P, Verkarre V et al (2007) Nodular regenerative hyperplasia is a new cause of chronic liver disease in HIV-infected patients. AIDS 21:187–192PubMed

11.

Mallet VO, Varthaman A, Lasne D et al (2009) Acquired protein S deficiency leads to obliterative portal venopathy and to compensatory nodular regenerative hyperplasia in HIV-infected patients. AIDS 23:1511–1518PubMed

12.

Solis-Herruzo JA, Vidal JV, Colina F, Santalla F, Castellano G (1986) Nodular regenerative hyperplasia of the liver associated with the toxic oil syndrome: report of five cases. Hepatology 6:687–693PubMed

13.

Seiderer J, Zech CJ, Reinisch W et al (2005) A multicenter assessment of liver toxicity by MRI and biopsy in IBD patients on 6-thioguanine. J Hepatol 43:303–309PubMed

14.

Bajaj JS, Bhattacharjee J, Sarin SK (2001) Coagulation profile and platelet function in patients with extrahepatic portal vein obstruction and non-cirrhotic portal fibrosis. J Gastroenterol Hepatol 16:641–646PubMed

15.

Maida I, Núñez M, Ríos MJ et al (2006) Severe liver disease associated with prolonged exposure to antiretroviral drugs. J Acquir Immune Defic Syndr 42:177–182PubMed

16.

Dinh MH, Stosor V, Rao SM, Miller FH, Green RM (2009) Cryptogenic liver disease in HIV-seropositive men. HIV Med 10:447–453PubMed

17.

Mallet VO, Vallet-Pichard A, Pol S (2009) Human immunodeficiency virus-associated obliterative portopathy underlies unexplained aminotransferase elevations under antiretrovirals. Hepatology 50:660PubMed

18.

Mallet VO, Sultanik PS, Vallet-Pichard A, Pol S (2010) HIV-associated obliterative portopathy (HIV-OP) underlies cryptogenic liver disease in HIV-seropositive patients. HIV Med 11:540–541PubMed

19.

Schouten JN, Van der Ende ME, Koëter T et al (2012) Risk factors and outcome of HIV-associated idiopathic noncirrhotic portal hypertension. Aliment Pharmacol Ther 36:875–885PubMed

20.

Saifee S, Joelson D, Braude J et al (2008) Noncirrhotic portal hypertension in patients with human immunodeficiency virus-1 infection. Clin Gastroenterol Hepatol 6:1167–1169PubMed

21.

Wanless IR, Peterson P, Das A, Boitnott JK, Moore GW, Bernier V (1990) Hepatic vascular disease and portal hypertension in polycythemia vera and agnogenic myeloid metaplasia: a clinicopathological study of 145 patients examined at autopsy. Hepatology 12:1166–1174PubMed

22.

Wanless IR, Godwin TA, Allen F, Feder A (1980) Nodular regenerative hyperplasia of the liver in hematologic disorders: a possible response to obliterative portal venopathy. A morphometric study of nine cases with an hypothesis on the pathogenesis. Medicine (Baltimore) 59:36779

23.

Glatard AS, Hillaire S, d’Assignies G et al (2012) Obliterative portal venopathy: findings at CT imaging. Radiology 263:741–750PubMed

24.

Laharie D, Vergniol J, Bioulac-Sage P et al (2010) Usefulness of noninvasive tests in nodular regenerative hyperplasia of the liver. Eur J Gastroenterol Hepatol 22:487–493PubMed

25.

Zech CJ, Seiderer J, Reinisch W et al (2007) Thioguanin-induced nodular regenerative hyperplasia of the liver-ROC analysis of different MR techniques. Eur Radiol 17:1898–1905PubMed

26.

Arora A, Sarin SK (2015) Multimodality imaging of obliterative portal venopathy: what every radiologist should know. Br J Radiol 88:20140653PubMedPubMedCentral

27.

Mikkelsen WP, Edmondson HA, Peters RL, Redeker AG, Reynolds TB (1965) Extra- and intrahepatic portal hypertension without cirrhosis (hepatoportal sclerosis). Ann Surg 162:602–620PubMedPubMedCentral

28.

Kirchgesner T, Perlepe V, Michoux N, Larbi A, Vande Berg B (2018) Fat suppression at three-dimensional T1-weighted MR imaging of the hands: Dixon method versus CHESS technique. Diagn Interv Imaging 99:23–28PubMed

29.

Soyer P, Sirol M, Dohan A et al (2012) Hepatic height on coronal computed tomography images predicts total liver volume in European adults without liver disease. Dig Dis Sci 57:1692–1697PubMed

30.

Lafortune M, Matricardi L, Denys A, Favret M, Déry R, Pomier-Layrargues G (1998) Segment 4 (the quadrate lobe): a barometer of cirrhotic liver disease at US. Radiology 206:157–160PubMed

31.

Prassopoulos P, Daskalogiannaki M, Raissaki M, Hatjidakis A, Gourtsoyiannis N (1991) Determination of normal splenic volume on computed tomography in relation to age, gender and body habitus. Eur Radiol 7:246–248

32.

Awaya H, Mitchell DG, Kamishima T, Holland G, Ito K, Matsumoto T (2002) Cirrhosis: modified caudate-right lobe ratio. Radiology 224:769–774PubMed

33.

Weinreb J, Kumari S, Phillips G, Pochaczevsky R (1982) Portal vein measurements by real-time sonography. AJR Am J Roentgenol 139:497–499PubMed

34.

Moriyasu F, Ban N, Nishida O et al (1986) Clinical application of an ultrasonic duplex system in the quantitative measurement of portal blood flow. J Clin Ultrasound 14:579–588PubMed

35.

Brancatelli G, Federle MP, Ambrosini R et al (2007) Cirrhosis: CT and MR imaging evaluation. Eur J Radiol 61:57–69PubMed

36.

Tonan T, Fujimoto K, Qayyum A (2010) Chronic hepatitis and cirrhosis on MR imaging. Magn Reson Imaging Clin N Am 18:383–402PubMed

37.

Ito K, Mitchell DG, Gabata T, Hussain SM (1999) Expanded gallbladder fossa: simple MR imaging sign of cirrhosis. Radiology 211:723–726PubMed

38.

Ito K, Mitchell DG, Kim MJ, Awaya H, Koike S, Matsunaga N (2003) Right posterior hepatic notch sign: a simple diagnostic MR finding of cirrhosis. J Magn Reson Imaging 18:561–566PubMed

39.

Rofsky NM, Weinreb JC, Ambrosino MM, Safir J, Krinsky G (1996) Comparison between in-phase and opposed-phase T1-weighted breath-hold FLASH sequences for hepatic imaging. J Comput Assist Tomogr 20:230–235PubMed

40.

Leiber LM, Boursier J, Michalak S et al (2015) MRI versus histological methods for time course monitoring of steatosis amount in a murine model of NAFLD. Diagn Interv Imaging 96:915–922PubMed

41.

Soyer P, Dufresne AC, Somveille E, Scherrer A (1996) Focal nodular hyperplasia of the liver: assessment of hemodynamic and angioarchitectural patterns with gadolinium chelate-enhanced 3D spoiled gradient-recalled MRI and maximum intensity projection reformatted images. J Comput Assist Tomogr 20:898–904PubMed

42.

Barral M, Sirol M, Placé V et al (2012) Hepatic and pancreatic involvement in hereditary hemorrhagic telangiectasia: quantitative and qualitative evaluation with 64-section CT in asymptomatic adult patients. Eur Radiol 22:161–170PubMed

43.

Ravard G, Soyer P, Boudiaf M et al (2004) Hepatic involvement in hereditary hemorrhagic telangiectasia: helical computed tomography features in 24 consecutive patients. J Comput Assist Tomogr 28:488–495PubMed

44.

Naganuma H, Ishida H, Niizawa M, Igarashi K, Shioya T, Masamune O (1995) Hepatic involvement in Osler-Weber-Rendu disease: findings on pulsed and color Doppler sonography. AJR Am J Roentgenol 165:1421–1425PubMed

45.

Waguri N, Suda T, Kamura T, Aoyagi Y (2002) Heterogeneous hepatic enhancement on CT angiography in idiopathic portal hypertension. Liver 22:276–280PubMed

46.

Yoshida M, Nakaura T, Inoue T et al (2018) Magnetic resonance cholangiopancreatography with GRASE sequence at 3.0T: does it improve image quality and acquisition time as compared with 3D TSE? Eur Radiol 28:2436–2443PubMed

47.

Nam JG, Lee JM, Kang HJ et al (2018) GRASE revisited: breath-hold three-dimensional (3D) magnetic resonance cholangiopancreatography using a gradient and spin echo (GRASE) technique at 3T. Eur Radiol 28:3721–3728PubMed

48.

Hocquelet A, Frulio N, Gallo G et al (2018) Point-shear wave elastography predicts liver hypertrophy after portal vein embolization and postoperative liver failure. Diagn Interv Imaging 99:371–379PubMed

Titel: Can we differentiate HIV-associated obliterative portopathy from liver cirrhosis using MRI?
verfasst von: Esther Chouraqui
Laura Leguilloux
Anthony Dohan
Hervé Gouya
Matthias Barral
Anais Vallet-Pichard
Philippe Sogni
Stanislas Pol
Vincent Mallet
Philippe Soyer
Publikationsdatum: 13.08.2019
Verlag: Springer Berlin Heidelberg
Erschienen in: European Radiology / Ausgabe 1/2020
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI: https://doi.org/10.1007/s00330-019-06391-6

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Can we differentiate HIV-associated obliterative portopathy from liver cirrhosis using MRI?

Abstract